Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Min, Kyung-Jin | - |
dc.contributor.author | Kwon, Sang-Hoon | - |
dc.contributor.author | Kim, Sunghoon | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Seong, Seok Ju | - |
dc.contributor.author | Song, Yong Jung | - |
dc.contributor.author | Shin, Jin Woo | - |
dc.contributor.author | Lee, Keun-Ho | - |
dc.contributor.author | Lim, Myong Cheol | - |
dc.contributor.author | Chung, Hyun Hoon | - |
dc.contributor.author | Ju, Woong | - |
dc.contributor.author | Hong, Jin Hwa | - |
dc.contributor.author | Lee, Jeong-Won | - |
dc.contributor.author | Kim, Jae-Weon | - |
dc.contributor.author | Bae, Duk-Soo | - |
dc.contributor.author | Lee, Jae-Kwan | - |
dc.date.available | 2020-02-28T01:46:17Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-05 | - |
dc.identifier.issn | 2005-0380 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8320 | - |
dc.description.abstract | After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY | - |
dc.relation.isPartOf | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.title | Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000383738300007 | - |
dc.identifier.doi | 10.3802/jgo.2016.27.e30 | - |
dc.identifier.bibliographicCitation | JOURNAL OF GYNECOLOGIC ONCOLOGY, v.27, no.3 | - |
dc.identifier.kciid | ART002105555 | - |
dc.identifier.scopusid | 2-s2.0-84962343719 | - |
dc.citation.title | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.citation.volume | 27 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Shin, Jin Woo | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Human Papillomavirus Vaccine | - |
dc.subject.keywordAuthor | Uterine Cervical Neoplasms | - |
dc.subject.keywordPlus | HUMAN-PAPILLOMAVIRUS TYPE-16 | - |
dc.subject.keywordPlus | HPV-16/18 AS04-ADJUVANTED VACCINE | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | OF-STUDY ANALYSIS | - |
dc.subject.keywordPlus | AGED 15-55 YEARS | - |
dc.subject.keywordPlus | PARTICLE VACCINE | - |
dc.subject.keywordPlus | YOUNG-WOMEN | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | INTRAEPITHELIAL NEOPLASIA | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.